By gene profiling of aorta samples and evaluation of anti-inflammatory properties of semaglutide in an acute in vivo inflammation model Rakipovski G, et al. (27) showed GLP-1RAs (glucagon-like peptide-1 receptor agonists) take part in modulation of atherosclerosis. This evidence concerns the gene GLP1R and atherosclerosis.